The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In Vitro Testing for Infectious Diseases Market Research Report 2025
Synopsis
In vitro diagnostic (IVD) testing for infectious diseases involves laboratory-based analysis of biological samples, such as blood, urine, or swabs, to detect the presence of infectious agents or markers associated with infections. These tests play a crucial role in the diagnosis, monitoring, and management of infectious diseases.
The global In Vitro Testing for Infectious Diseases market was valued at US$ 30660 million in 2023 and is anticipated to reach US$ 48100 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
The In Vitro Testing for Infectious Diseases market is driven by the global demand for rapid and accurate diagnostic solutions, particularly in the context of infectious diseases. In vitro diagnostic devices, encompassing molecular assays, immunoassays, and nucleic acid-based tests, play a pivotal role in the early detection and management of infectious pathogens. The ongoing threat of pandemics, such as the COVID-19 pandemic, has accelerated the need for advanced testing technologies. Additionally, the increasing prevalence of infectious diseases worldwide, coupled with initiatives to control their spread, fuels the market's growth. Technological innovations, including point-of-care testing, contribute to the market's dynamism, addressing the urgent need for timely and reliable infectious disease diagnostics.
This report aims to provide a comprehensive presentation of the global market for In Vitro Testing for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Testing for Infectious Diseases.
Report Scope
The In Vitro Testing for Infectious Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Testing for Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Testing for Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
KHB
Daan Gene
Leadman
Zhongsheng
Bsbe
Maccura
Hitachi
Canon
Sysmex
Auto Bio
Mindray
Bgi
Wondfo
Segment by Type
Consumables
Equipment
Segment by Application
Hepatitis
Pneumonia
Sexually Transmitted Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Testing for Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In vitro diagnostic (IVD) testing for infectious diseases involves laboratory-based analysis of biological samples, such as blood, urine, or swabs, to detect the presence of infectious agents or markers associated with infections. These tests play a crucial role in the diagnosis, monitoring, and management of infectious diseases.
The global In Vitro Testing for Infectious Diseases market was valued at US$ 30660 million in 2023 and is anticipated to reach US$ 48100 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
The In Vitro Testing for Infectious Diseases market is driven by the global demand for rapid and accurate diagnostic solutions, particularly in the context of infectious diseases. In vitro diagnostic devices, encompassing molecular assays, immunoassays, and nucleic acid-based tests, play a pivotal role in the early detection and management of infectious pathogens. The ongoing threat of pandemics, such as the COVID-19 pandemic, has accelerated the need for advanced testing technologies. Additionally, the increasing prevalence of infectious diseases worldwide, coupled with initiatives to control their spread, fuels the market's growth. Technological innovations, including point-of-care testing, contribute to the market's dynamism, addressing the urgent need for timely and reliable infectious disease diagnostics.
This report aims to provide a comprehensive presentation of the global market for In Vitro Testing for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Testing for Infectious Diseases.
Report Scope
The In Vitro Testing for Infectious Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Testing for Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Testing for Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
KHB
Daan Gene
Leadman
Zhongsheng
Bsbe
Maccura
Hitachi
Canon
Sysmex
Auto Bio
Mindray
Bgi
Wondfo
Segment by Type
Consumables
Equipment
Segment by Application
Hepatitis
Pneumonia
Sexually Transmitted Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Testing for Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Equipment
1.3 Market by Application
1.3.1 Global In Vitro Testing for Infectious Diseases Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hepatitis
1.3.3 Pneumonia
1.3.4 Sexually Transmitted Diseases
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Testing for Infectious Diseases Market Perspective (2019-2030)
2.2 In Vitro Testing for Infectious Diseases Growth Trends by Region
2.2.1 Global In Vitro Testing for Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vitro Testing for Infectious Diseases Historic Market Size by Region (2019-2024)
2.2.3 In Vitro Testing for Infectious Diseases Forecasted Market Size by Region (2025-2030)
2.3 In Vitro Testing for Infectious Diseases Market Dynamics
2.3.1 In Vitro Testing for Infectious Diseases Industry Trends
2.3.2 In Vitro Testing for Infectious Diseases Market Drivers
2.3.3 In Vitro Testing for Infectious Diseases Market Challenges
2.3.4 In Vitro Testing for Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Testing for Infectious Diseases Players by Revenue
3.1.1 Global Top In Vitro Testing for Infectious Diseases Players by Revenue (2019-2024)
3.1.2 Global In Vitro Testing for Infectious Diseases Revenue Market Share by Players (2019-2024)
3.2 Global In Vitro Testing for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Testing for Infectious Diseases Revenue
3.4 Global In Vitro Testing for Infectious Diseases Market Concentration Ratio
3.4.1 Global In Vitro Testing for Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Testing for Infectious Diseases Revenue in 2023
3.5 In Vitro Testing for Infectious Diseases Key Players Head office and Area Served
3.6 Key Players In Vitro Testing for Infectious Diseases Product Solution and Service
3.7 Date of Enter into In Vitro Testing for Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Testing for Infectious Diseases Breakdown Data by Type
4.1 Global In Vitro Testing for Infectious Diseases Historic Market Size by Type (2019-2024)
4.2 Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Type (2025-2030)
5 In Vitro Testing for Infectious Diseases Breakdown Data by Application
5.1 Global In Vitro Testing for Infectious Diseases Historic Market Size by Application (2019-2024)
5.2 Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vitro Testing for Infectious Diseases Market Size (2019-2030)
6.2 North America In Vitro Testing for Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024)
6.4 North America In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Testing for Infectious Diseases Market Size (2019-2030)
7.2 Europe In Vitro Testing for Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024)
7.4 Europe In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Testing for Infectious Diseases Market Size (2019-2030)
8.2 Asia-Pacific In Vitro Testing for Infectious Diseases Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vitro Testing for Infectious Diseases Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vitro Testing for Infectious Diseases Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Testing for Infectious Diseases Market Size (2019-2030)
9.2 Latin America In Vitro Testing for Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024)
9.4 Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Testing for Infectious Diseases Market Size (2019-2030)
10.2 Middle East & Africa In Vitro Testing for Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche In Vitro Testing for Infectious Diseases Introduction
11.1.4 Roche Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Siemens
11.2.1 Siemens Company Detail
11.2.2 Siemens Business Overview
11.2.3 Siemens In Vitro Testing for Infectious Diseases Introduction
11.2.4 Siemens Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.2.5 Siemens Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott In Vitro Testing for Infectious Diseases Introduction
11.3.4 Abbott Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher In Vitro Testing for Infectious Diseases Introduction
11.4.4 Danaher Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Detail
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher In Vitro Testing for Infectious Diseases Introduction
11.5.4 Thermo Fisher Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.5.5 Thermo Fisher Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Detail
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux In Vitro Testing for Infectious Diseases Introduction
11.6.4 BioMerieux Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.6.5 BioMerieux Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad In Vitro Testing for Infectious Diseases Introduction
11.7.4 Bio-Rad Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.7.5 Bio-Rad Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD In Vitro Testing for Infectious Diseases Introduction
11.8.4 BD Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.8.5 BD Recent Development
11.9 KHB
11.9.1 KHB Company Detail
11.9.2 KHB Business Overview
11.9.3 KHB In Vitro Testing for Infectious Diseases Introduction
11.9.4 KHB Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.9.5 KHB Recent Development
11.10 Daan Gene
11.10.1 Daan Gene Company Detail
11.10.2 Daan Gene Business Overview
11.10.3 Daan Gene In Vitro Testing for Infectious Diseases Introduction
11.10.4 Daan Gene Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.10.5 Daan Gene Recent Development
11.11 Leadman
11.11.1 Leadman Company Detail
11.11.2 Leadman Business Overview
11.11.3 Leadman In Vitro Testing for Infectious Diseases Introduction
11.11.4 Leadman Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.11.5 Leadman Recent Development
11.12 Zhongsheng
11.12.1 Zhongsheng Company Detail
11.12.2 Zhongsheng Business Overview
11.12.3 Zhongsheng In Vitro Testing for Infectious Diseases Introduction
11.12.4 Zhongsheng Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.12.5 Zhongsheng Recent Development
11.13 Bsbe
11.13.1 Bsbe Company Detail
11.13.2 Bsbe Business Overview
11.13.3 Bsbe In Vitro Testing for Infectious Diseases Introduction
11.13.4 Bsbe Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.13.5 Bsbe Recent Development
11.14 Maccura
11.14.1 Maccura Company Detail
11.14.2 Maccura Business Overview
11.14.3 Maccura In Vitro Testing for Infectious Diseases Introduction
11.14.4 Maccura Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.14.5 Maccura Recent Development
11.15 Hitachi
11.15.1 Hitachi Company Detail
11.15.2 Hitachi Business Overview
11.15.3 Hitachi In Vitro Testing for Infectious Diseases Introduction
11.15.4 Hitachi Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.15.5 Hitachi Recent Development
11.16 Canon
11.16.1 Canon Company Detail
11.16.2 Canon Business Overview
11.16.3 Canon In Vitro Testing for Infectious Diseases Introduction
11.16.4 Canon Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.16.5 Canon Recent Development
11.17 Sysmex
11.17.1 Sysmex Company Detail
11.17.2 Sysmex Business Overview
11.17.3 Sysmex In Vitro Testing for Infectious Diseases Introduction
11.17.4 Sysmex Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.17.5 Sysmex Recent Development
11.18 Auto Bio
11.18.1 Auto Bio Company Detail
11.18.2 Auto Bio Business Overview
11.18.3 Auto Bio In Vitro Testing for Infectious Diseases Introduction
11.18.4 Auto Bio Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.18.5 Auto Bio Recent Development
11.19 Mindray
11.19.1 Mindray Company Detail
11.19.2 Mindray Business Overview
11.19.3 Mindray In Vitro Testing for Infectious Diseases Introduction
11.19.4 Mindray Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.19.5 Mindray Recent Development
11.20 Bgi
11.20.1 Bgi Company Detail
11.20.2 Bgi Business Overview
11.20.3 Bgi In Vitro Testing for Infectious Diseases Introduction
11.20.4 Bgi Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.20.5 Bgi Recent Development
11.21 Wondfo
11.21.1 Wondfo Company Detail
11.21.2 Wondfo Business Overview
11.21.3 Wondfo In Vitro Testing for Infectious Diseases Introduction
11.21.4 Wondfo Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024)
11.21.5 Wondfo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global In Vitro Testing for Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Consumables
Table 3. Key Players of Equipment
Table 4. Global In Vitro Testing for Infectious Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global In Vitro Testing for Infectious Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global In Vitro Testing for Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global In Vitro Testing for Infectious Diseases Market Share by Region (2019-2024)
Table 8. Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global In Vitro Testing for Infectious Diseases Market Share by Region (2025-2030)
Table 10. In Vitro Testing for Infectious Diseases Market Trends
Table 11. In Vitro Testing for Infectious Diseases Market Drivers
Table 12. In Vitro Testing for Infectious Diseases Market Challenges
Table 13. In Vitro Testing for Infectious Diseases Market Restraints
Table 14. Global In Vitro Testing for Infectious Diseases Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global In Vitro Testing for Infectious Diseases Market Share by Players (2019-2024)
Table 16. Global Top In Vitro Testing for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Testing for Infectious Diseases as of 2023)
Table 17. Ranking of Global Top In Vitro Testing for Infectious Diseases Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by In Vitro Testing for Infectious Diseases Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In Vitro Testing for Infectious Diseases Product Solution and Service
Table 21. Date of Enter into In Vitro Testing for Infectious Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In Vitro Testing for Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Type (2019-2024)
Table 25. Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Type (2025-2030)
Table 27. Global In Vitro Testing for Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Application (2019-2024)
Table 29. Global In Vitro Testing for Infectious Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global In Vitro Testing for Infectious Diseases Revenue Market Share by Application (2025-2030)
Table 31. North America In Vitro Testing for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe In Vitro Testing for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific In Vitro Testing for Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific In Vitro Testing for Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific In Vitro Testing for Infectious Diseases Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America In Vitro Testing for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa In Vitro Testing for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa In Vitro Testing for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa In Vitro Testing for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche In Vitro Testing for Infectious Diseases Product
Table 49. Roche Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Siemens Company Detail
Table 52. Siemens Business Overview
Table 53. Siemens In Vitro Testing for Infectious Diseases Product
Table 54. Siemens Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 55. Siemens Recent Development
Table 56. Abbott Company Detail
Table 57. Abbott Business Overview
Table 58. Abbott In Vitro Testing for Infectious Diseases Product
Table 59. Abbott Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Danaher Company Detail
Table 62. Danaher Business Overview
Table 63. Danaher In Vitro Testing for Infectious Diseases Product
Table 64. Danaher Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 65. Danaher Recent Development
Table 66. Thermo Fisher Company Detail
Table 67. Thermo Fisher Business Overview
Table 68. Thermo Fisher In Vitro Testing for Infectious Diseases Product
Table 69. Thermo Fisher Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 70. Thermo Fisher Recent Development
Table 71. BioMerieux Company Detail
Table 72. BioMerieux Business Overview
Table 73. BioMerieux In Vitro Testing for Infectious Diseases Product
Table 74. BioMerieux Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 75. BioMerieux Recent Development
Table 76. Bio-Rad Company Detail
Table 77. Bio-Rad Business Overview
Table 78. Bio-Rad In Vitro Testing for Infectious Diseases Product
Table 79. Bio-Rad Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 80. Bio-Rad Recent Development
Table 81. BD Company Detail
Table 82. BD Business Overview
Table 83. BD In Vitro Testing for Infectious Diseases Product
Table 84. BD Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 85. BD Recent Development
Table 86. KHB Company Detail
Table 87. KHB Business Overview
Table 88. KHB In Vitro Testing for Infectious Diseases Product
Table 89. KHB Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 90. KHB Recent Development
Table 91. Daan Gene Company Detail
Table 92. Daan Gene Business Overview
Table 93. Daan Gene In Vitro Testing for Infectious Diseases Product
Table 94. Daan Gene Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 95. Daan Gene Recent Development
Table 96. Leadman Company Detail
Table 97. Leadman Business Overview
Table 98. Leadman In Vitro Testing for Infectious Diseases Product
Table 99. Leadman Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 100. Leadman Recent Development
Table 101. Zhongsheng Company Detail
Table 102. Zhongsheng Business Overview
Table 103. Zhongsheng In Vitro Testing for Infectious Diseases Product
Table 104. Zhongsheng Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 105. Zhongsheng Recent Development
Table 106. Bsbe Company Detail
Table 107. Bsbe Business Overview
Table 108. Bsbe In Vitro Testing for Infectious Diseases Product
Table 109. Bsbe Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 110. Bsbe Recent Development
Table 111. Maccura Company Detail
Table 112. Maccura Business Overview
Table 113. Maccura In Vitro Testing for Infectious Diseases Product
Table 114. Maccura Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 115. Maccura Recent Development
Table 116. Hitachi Company Detail
Table 117. Hitachi Business Overview
Table 118. Hitachi In Vitro Testing for Infectious Diseases Product
Table 119. Hitachi Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 120. Hitachi Recent Development
Table 121. Canon Company Detail
Table 122. Canon Business Overview
Table 123. Canon In Vitro Testing for Infectious Diseases Product
Table 124. Canon Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 125. Canon Recent Development
Table 126. Sysmex Company Detail
Table 127. Sysmex Business Overview
Table 128. Sysmex In Vitro Testing for Infectious Diseases Product
Table 129. Sysmex Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 130. Sysmex Recent Development
Table 131. Auto Bio Company Detail
Table 132. Auto Bio Business Overview
Table 133. Auto Bio In Vitro Testing for Infectious Diseases Product
Table 134. Auto Bio Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 135. Auto Bio Recent Development
Table 136. Mindray Company Detail
Table 137. Mindray Business Overview
Table 138. Mindray In Vitro Testing for Infectious Diseases Product
Table 139. Mindray Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 140. Mindray Recent Development
Table 141. Bgi Company Detail
Table 142. Bgi Business Overview
Table 143. Bgi In Vitro Testing for Infectious Diseases Product
Table 144. Bgi Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 145. Bgi Recent Development
Table 146. Wondfo Company Detail
Table 147. Wondfo Business Overview
Table 148. Wondfo In Vitro Testing for Infectious Diseases Product
Table 149. Wondfo Revenue in In Vitro Testing for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 150. Wondfo Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vitro Testing for Infectious Diseases Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global In Vitro Testing for Infectious Diseases Market Share by Type: 2023 VS 2030
Figure 3. Consumables Features
Figure 4. Equipment Features
Figure 5. Global In Vitro Testing for Infectious Diseases Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global In Vitro Testing for Infectious Diseases Market Share by Application: 2023 VS 2030
Figure 7. Hepatitis Case Studies
Figure 8. Pneumonia Case Studies
Figure 9. Sexually Transmitted Diseases Case Studies
Figure 10. Other Case Studies
Figure 11. In Vitro Testing for Infectious Diseases Report Years Considered
Figure 12. Global In Vitro Testing for Infectious Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global In Vitro Testing for Infectious Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global In Vitro Testing for Infectious Diseases Market Share by Region: 2023 VS 2030
Figure 15. Global In Vitro Testing for Infectious Diseases Market Share by Players in 2023
Figure 16. Global Top In Vitro Testing for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Testing for Infectious Diseases as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by In Vitro Testing for Infectious Diseases Revenue in 2023
Figure 18. North America In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America In Vitro Testing for Infectious Diseases Market Share by Country (2019-2030)
Figure 20. United States In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe In Vitro Testing for Infectious Diseases Market Share by Country (2019-2030)
Figure 24. Germany In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific In Vitro Testing for Infectious Diseases Market Share by Region (2019-2030)
Figure 32. China In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America In Vitro Testing for Infectious Diseases Market Share by Country (2019-2030)
Figure 40. Mexico In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa In Vitro Testing for Infectious Diseases Market Share by Country (2019-2030)
Figure 44. Turkey In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia In Vitro Testing for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 47. Siemens Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 48. Abbott Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 49. Danaher Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 50. Thermo Fisher Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 51. BioMerieux Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 52. Bio-Rad Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 53. BD Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 54. KHB Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 55. Daan Gene Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 56. Leadman Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 57. Zhongsheng Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 58. Bsbe Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 59. Maccura Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 60. Hitachi Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 61. Canon Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 62. Sysmex Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 63. Auto Bio Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 64. Mindray Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 65. Bgi Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 66. Wondfo Revenue Growth Rate in In Vitro Testing for Infectious Diseases Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
